Emerging drugs in endometriosis-Reference-Cited by-同舟云学术

Emerging drugs in endometriosis

Published:2006-08-29 Issue:3 Volume:11 Page:503-524
ISSN:1472-8214
Container-title:Expert Opinion on Emerging Drugs
language:en
Short-container-title:Expert Opinion on Emerging Drugs

Author:

Mihalyi Attila,Simsa Peter,Mutinda Kyama C,Meuleman Christel,Mwenda Jason M,D’Hooghe Thomas M

Publisher

Informa Healthcare

Subject

Pharmacology (medical),Pharmacology

Link

http://www.tandfonline.com/doi/pdf/10.1517/14728214.11.3.503

Reference180 articles.

1. Role of immunologic and inflammatory factors in the development of endometriosis: indications for treatment strategies

2. The genetic basis of endometriosis

3. D’HOOGHE TM, HILL JA: Endometriosis. In:Novak’s Gynecology. Reproductive endocrinology. JS Berek (Ed.), Williams & Wilkins, Baltimore, USA (1996):887-914.

Cited by 36 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Importance of Medicinal Compounds from Traditional Plants for the Treatment of Endometriosis;Genetic Manipulation of Secondary Metabolites in Medicinal Plant;2023

2. Exploration of the Modulatory Property Mechanism of ELeng Capsule in the Treatment of Endometriosis Using Transcriptomics Combined With Systems Network Pharmacology;Frontiers in Pharmacology;2021-06-18

3. Modular Characteristics and Mechanism of Action of Herbs for Endometriosis Treatment in Chinese Medicine: A Data Mining and Network Pharmacology–Based Identification;Frontiers in Pharmacology;2020-03-06

4. Nobiletin alleviates endometriosis via down-regulating NF-κB activity in endometriosis mouse model;Bioscience Reports;2018-06-21

5. Effect of the estrus cycle stage on the establishment of murine endometriosis lesions;International Journal of Reproductive BioMedicine;2018-05-01